Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8. - Wikidata - wikimedia - TriplyDB

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

http://www.wikidata.org/entity/Q34386518

about

CpG Oligonucleotides as Cancer Vaccine Adjuvants Sensors of Infection: Viral Nucleic Acid PRRs in Fish Inhibition of human immunodeficiency virus type-1 through autophagy Toll-like receptors in antiviral innate immunity TLR8: the forgotten relative revindicated Native cellulose nanofibrills induce immune tolerance in vitro by acting on dendritic cells Activation of anti-hepatitis C virus responses via Toll-like receptor 7.Investigating Toll-Like Receptor Agonists for Potential To Treat Hepatitis C Virus Infection Hepatitis C and Innate Immunity: Recent Advances Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses Structure-Based Design of Novel Human Toll-like Receptor 8 Agonists Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity Imiquimod: mode of action Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1 Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands Induction of type I interferon by RNA viruses: cellular receptors and their substrates Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy VTX-1463, a novel TLR-8 agonist, attenuates nasal congestion after ragweed challenge in sensitized beagle dogs.Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response Ex vivo induction of IFN-λ3 by a TLR7 agonist determines response to Peg-IFN/ribavirin therapy in chronic hepatitis C patients.Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta Genomics of antiviral defenses in the duck, a natural host of influenza and hepatitis B viruses.Transcriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonists Anti-HIV activity mediated by natural killer and CD8+ cells after toll-like receptor 7/8 triggering Comparison of human B cell activation by TLR7 and TLR9 agonists.Targeting aerobic glycolysis and HIF-1alpha expression enhance imiquimod-induced apoptosis in cancer cells.Borrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokines Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation.Drug delivery-mediated control of RNA immunostimulation The therapeutic potential of Toll-like receptor 7 stimulation in asthma.Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands.TLR8-mediated activation of human monocytes inhibits TL1A expression.Effect of activation of Toll-like receptor 7 in the inhibition of allergic asthma on a mouse model Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors Dendritic cell-based human immunodeficiency virus vaccine.Toll-like receptor-7 agonist administered subcutaneously in a prolonged dosing schedule in heavily pretreated recurrent breast, ovarian, and cervix cancers Toll-like receptor agonists in cancer therapy.Imiquimod-induced TLR7 signaling enhances repair of DNA damage induced by ultraviolet light in bone marrow-derived cells Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response.Poly-thymidine oligonucleotides mediate activation of murine glial cells primarily through TLR7, not TLR8.

P2860

Q26783826-8CEFB43E-C76D-4A4F-A38F-8E8685340E74 Q26799867-A7A000E4-305E-42BF-AFDF-C10816741F3C Q27005938-14DD59CA-292F-41AB-9367-AC3647431307 Q27011462-B48D9902-A6E4-4DBD-BF41-353DE46BD9DE Q27026056-8D71A8F1-BA98-4AB0-AB7A-EB9273024DD1 Q27317032-EAECFED2-9D44-4FA4-B86A-C1087507BBB3 Q27473105-BE9A5C3D-D655-470D-8F81-2C395AD840D7 Q27480922-E1078F28-B57F-4F77-9A05-92D759710FE5 Q27487394-BEFE49A1-8B87-4A6B-8F31-49FD14B4B249 Q27487514-BC1BD30F-4755-43A5-A2DF-FB3EC61CF695 Q27681499-4F07C4FD-14EC-410B-AF74-5F1818FE85AB Q28250405-A6BABD30-4D34-4979-B823-7E17CBF4FA41 Q28260444-649D2A6A-8B29-4D5D-AF13-A0F288C8EAF2 Q28485225-2CC93409-AA96-4A37-A737-5BA5579D1BC8 Q28972540-16B74694-638E-4BE4-AC59-54077FBFF832 Q29042349-494E1B84-7F5D-42A5-AA1C-3C67A727D60E Q30275792-FC2645DC-EDA4-4B1A-9EB0-BCF08EB0C5BE Q30387055-824D32F2-E9C3-480C-81BD-71F4102768EE Q30397031-2FB3D924-0A01-4213-AE6A-5ED32FCE20E1 Q30444198-5CA1B522-F349-4CF2-864B-5FC08271E6A7 Q30498311-BFAC2695-5866-492C-86C0-0848BC150F2E Q33293060-622FB1B1-9C72-4125-943A-BA6630E084E6 Q33302568-16A70753-57A4-4E49-B59D-FB76ECD665A0 Q33330287-754EA158-FF25-49BB-872F-25371F3598C5 Q33354786-64A07424-15BB-4434-9026-BFDA984D8501 Q33576827-CEA11082-19FE-4616-A473-3936C6B9B0CC Q33603081-840005E6-0E68-4FDE-A724-DC46B8D48EC1 Q33613674-34E2ECF3-9354-424D-AAB8-4C0DA2726234 Q33713938-14A99333-AE8D-4B1E-A04E-646D03EF74AC Q33725167-D2073394-4919-42DA-8EF0-A629B0EDB7B3 Q33725882-48A5D764-2094-4649-8753-447D339559C0 Q33731098-6267F9D3-B53B-4A50-B927-6F98949BB624 Q33733105-C86807D6-D3AB-4572-ACDF-41D33BA9AC8F Q33824623-051E067D-F6B7-412F-A845-61D9C9246A76 Q33874652-48893FB7-BC9D-4B6C-B28A-93A8FE977D06 Q33903112-9830F5C0-87FE-488B-99FD-6004A1A17A3D Q33918509-9A9EC12C-D1DF-452D-BAD7-076FFBEBD9C4 Q33963409-CCDB7577-E8CE-4374-81D1-37E579B16396 Q33979882-6D32F1E3-1763-45BB-A635-7B3236295900 Q33979985-623A394B-C7CD-4ED4-8D10-75D71B144798

P2860

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

http://www.wikidata.org/entity/Q34386518

description

2005 nî lūn-bûn

@nan

2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

@ast

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

@en

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

@nl

type

label

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

@ast

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

@en

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

@nl

prefLabel

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

@ast

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

@en

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

@nl

P1433

Q34386518-AE24A008-B82C-4D58-ACDE-129C3F825E8A

P1476

Q34386518-7E496798-FE2D-4C41-A22A-1F387D0C57E9

P2093

Q34386518-201DF4D7-4E14-4564-904E-CC86C9DF6F5A

Q34386518-272BF7B9-AF75-4812-99A2-228ACC25A4BE

Q34386518-41116060-2BBE-4A76-B62D-F8B1E5CF185C

Q34386518-47A04684-B0B8-4EAF-8402-CF52A5883A5D

Q34386518-5B960514-5243-40B3-B2D5-D00AE5EEFB74

Q34386518-A118D913-CC2A-436E-9F15-4CB7615EB941

Q34386518-BB7016AF-4924-4C89-B83D-E82E79FC2B3F

Q34386518-D03C1844-4445-401F-8994-63497D4F6D2D

Q34386518-DB747686-817E-4546-A4AB-94C266401147

P304

Q34386518-7E5A1A17-C971-410E-A9C9-3C302EE285F1

P31

Q34386518-4EAB968B-F48B-4A44-BAD2-42BEDB7B2934

P356

Q34386518-28B0CB00-38B1-4C6E-82F9-45922AAA1065

P407

Q34386518-6A23949F-0240-4D40-836D-5973520B6473

P433

Q34386518-7D3BA428-9C1F-4553-B347-5C2D8044AE71

P478

Q34386518-3A4B2B5C-39BA-47FF-957F-7E250A4A53DE

P577

Q34386518-833AFC69-E101-43CC-AAEE-F790EDA70D7D

P5875

Q34386518-B2845EE9-ABD5-44C5-9EDB-543A5AB6A590

P698

Q34386518-A059A4E7-F572-47F5-85C8-4DA26D508528

P921

Q34386518-FBFCC4D4-5CF6-4C40-8907-715029A3B693

P356

JIMMUNOL.174.3.1259

P1433

Journal of Immunology

P1476

Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

@en

P2093

John P Vasilakos

http://www.w3.org/2001/XMLSchema#string

Keith B Gorden

http://www.w3.org/2001/XMLSchema#string

Kevin S Gorski

http://www.w3.org/2001/XMLSchema#string

Mark A Tomai

http://www.w3.org/2001/XMLSchema#string

Ross M Kedl

http://www.w3.org/2001/XMLSchema#string

Sefik S Alkan

http://www.w3.org/2001/XMLSchema#string

Sheila J Gibson

http://www.w3.org/2001/XMLSchema#string

William C Kieper

http://www.w3.org/2001/XMLSchema#string

Xiaohong Qiu

http://www.w3.org/2001/XMLSchema#string

P304

1259-1268

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.174.3.1259

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8069434

http://www.w3.org/2001/XMLSchema#string

P698

15661881

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor